Pattern-04.png
About
Vivaldi

Vivaldi Biosciences is a venture-backed company with operations at the Research Innovation Center at Colorado State University, Fort Collins, Colorado and Vienna, Austria. Our lead investor is NGN Capital LLC.

Our management team has extensive experience in the biotechnology and pharmaceutical industries, and expertise in reverse genetics, virology, immunology, vaccine development, and Vero cell process optimization and manufacturing. Vivaldi co-founders Drs. Peter Palese and Adolfo García-Sastre at the Icahn School of Medicine at Mount Sinai are pioneers in the fields of influenza genomics, influenza nonstructural protein 1 (NS1), and vaccine development. They support Vivaldi on an ongoing basis as scientific advisors.

 

Management & Board of Directors

 
 
Icons-27.jpg
 

William Wick, MBA

CEO, Board Member and
Managing Director


CEO, Vivaldi Biosciences Inc.

Board Member, Vivaldi Biosciences Inc.

Managing Director, Vivaldi Biosciences AG

Investment, finance and operating professional with extensive C-level leadership experience in venture-backed medical and high-tech companies

• Lumendi LLC

• Vision Capital LLC

• ZoZa.com

• QuickPower, Inc.

• National City Corporation

 
Icons-21.png
 

Thomas Muster, PhD

CSO, Board Member and
Managing Director


CSO, Vivaldi Biosciences Inc.

Board Member, Vivaldi Biosciences Inc.

Managing Director, Vivaldi Biosciences AG

Virologist and entrepreneur, expert in clinical development of novel vaccines, co-authored more than 50 publications, holds 30 patents

• Blue Sky Vaccines

• AVIR Green Hills Biotechnology

• Mount Sinai School of Medicine

 
Icons-19.png
 

Manfred Reiter, PhD

Senior Vice President,
Manufacturing


Senior Vice President, Manufacturing.

Leader in process development and manufacturing for human vaccines, expert in cell-based production and scale-up

• Blue Sky Vaccines

• Hookipa Biotech

• Baxter Bioscience

• Immuno AG


 
Icons-30.png
 

John Costantino, JD

Chairman


Chairman,Vivaldi Biosciences Inc.

Chairman, Supervisory Board, Vivaldi Biosciences AG

Managing General Partner, NGN Capital LLC

Expert in private equity, venture investing, and investment banking, C-level corporate experience, attorney, CPA

• Walden Partners

• Conair Corporation

• Integrated Resources Acquisition Corporation

• Touche Ross & Co.

 
Icons-29.png
 

Peter Johann, PhD

Director


Director, Vivaldi Biosciences Inc.

Member, Supervisory Board, Vivaldi Biosciences AG

Managing General Partner, NGN Capital LLC

Venture investor with extensive pharma industry experience including strategic planning, corporate development, M&A, marketing and licensing

• Boehringer Ingelheim

• Hoffmann-La Roche

• Boehringer Mannheim

 
Icons-26.png
 

Douglass Given, MD, PhD, MBA

Director


Director, Vivaldi Biosciences Inc.

Member, Supervisory Board, Vivaldi Biosciences AG

Managing Partner, Health 2047

Entrepreneur and venture capitalist with extensive pharma and biotech executive and board experience, physician

• Bay City Capital LLC

• Mallinckrodt

• Lilly

• Schering Plough


 

Scientific Advisors

 
 
Icons-24.png
 

Peter Palese, PhD

Founder & Scientific Advisor


Founder & Scientific Advisor, Vivaldi Biosciences Inc.

Professor & Chair, Microbiology, Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai

International leader in the study of viruses that cause respiratory diseases, influenza genomics, vaccines and antivirals, authored over 400 papers, holds multiple patents on vaccines and antivirals

• Member, National Academy of Sciences

• Member, Institute of Medicine

• Member, Austrian Academy of Sciences

• Member, German Academy of Sciences Leopoldina

• Member, American Academy of Arts and Sciences

 
Icons-22.png
 

Adolfo García-Sastre, PhD

Founder & Scientific Advisor


Founder & Scientific Advisor, Vivaldi Biosciences Inc.

Professor, Microbiology and Medicine; Director, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai

Expert in molecular biology of influenza and other negative strand RNA viruses, identified role of influenza NS1, co-developed reverse genetics techniques and live attenuated influenza viruses with modifications of NS1, authored over 480 papers and reviews

• Member, National Academy of Sciences

• Fellow, American Academy of Microbiology

• Fellow, Royal Academy of Pharmacy, Spain

 
Icons-23.png
 

Elliott Kieff, MD, PhD

Founder & Scientific Advisor


Founder & Scientific Advisor, Vivaldi Biosciences Inc.

Professor of Medicine, Emeritus, Harvard Medical School

Senior Physician, Brigham & Women’s Hospital

Expert in virology and medicine, led discoveries in genetics and molecular pathogenesis of Epstein-Barr virus infection resulting in development of vaccines and immunotherapeutics, authored more than 230 papers, holds 11 patents

• Member, National Academy of Sciences

• Member, Institute of Medicine

• Member, American Academy of Arts and Sciences